24.25 (-%)
As of Dec 06, 2024
Source:
Exicure, Inc. have been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets.
Country | United States |
Headquarters | chicago, illinois |
Phone Number | 847-673-1700 |
Industry | manufacturing |
CEO | Paul Kang |
Website | www.exicuretx.com |